Overview of Dr. Thomas
Dr. Sajeve Thomas is an oncologist in Orlando, FL and is affiliated with Orlando Health Orlando Regional Medical Center. He received his medical degree from University of Florida College of Medicine and has been in practice 12 years. He is one of 74 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology.
Office
1400 S Orange Ave
Orlando, FL 32806- Is this information wrong?
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 2008 - 2011
- University of South Florida MorsaniResidency, Internal Medicine, 2005 - 2008
- University of Florida College of MedicineClass of 2005
Certifications & Licensure
- FL State Medical License 2007 - 2026
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Start of enrollment: 2012 Dec 17
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsIndividualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.Weber, J., Carlino, M., Khattak, A., Meniawy, T., Ansstas, G., Taylor, M., Kim, K., McKean, M., Long, G., Sullivan, R., Faries, M., Tran, T., Cowey, C., Pecora, A., Sh...> ;Lancet. 2024 Feb 17
- 28 citationsEfficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immu...Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood,...> ;Journal for Immunotherapy of Cancer. 2022 Dec 1
- 6 citationsMulticenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem, Svetomir N. Markovic, Tawnya L. Bowles, Omid Hamid, Leonel Hernandez-A...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
- Join now to see all
Press Mentions
- Cancer Specialists in Florida See Dramatic Results with New Clinical TrialNovember 22nd, 2021
- Iovance: Assessing the Potential for Further UpsideMay 20th, 2019
Hospital Affiliations
- Orlando Health Orlando Regional Medical CenterOrlando, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: